Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer

Kexun Zhou(Sichuan University), Qiu Li(Fuzhou University), Nan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaxing Huang(Northwestern University), Liangliang Bai(Sichuan University), Jing Zhou(Sichuan University), Yu Yang(Sichuan University)

Lung Cancer

February 1, 2019

Cited by 75

|Journal of the American Chemical Society|2002|1.7k

|Journal of the American Chemical Society|2003|1.4k

|Nano Letters|2004|1.1k

|Accounts of Chemical Research|2008|1k

|Nano Letters|2005|830

Related Papers